This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Alexza Pharmaceuticals Inc (ALXA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 17.31M 17.72M 14.90M 13.67M
Receivables 129.00K 0.00 10.00M 0.00
Inventories 3.45M 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 30.91M 23.62M 27.55M 42.41M
Property, Plant & Equipment, Gross 43.96M 42.40M 45.08M 45.05M
Accumulated Depreciation & Depletion 28.97M 25.86M 24.65M 20.69M
Property, Plant & Equipment, Net 14.99M 16.53M 20.42M 24.36M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.17M 402.00K 628.00K 1.71M
Total Non-Current Assets 16.16M 16.93M 21.05M 26.07M
Liabilities & Shareholder Equity
Total Assets 47.07M 40.55M 48.60M 68.48M
Accounts Payable 3.79M 2.15M 3.60M 2.78M
Short Term Debt 780.00K 6.46M 12.28M 0.00
Other Current Liabilities 2.50M 3.50M 12.30M 23.90M
Total Current Liabilities 14.90M 18.72M 34.95M 34.38M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 6.40M 8.06M 12.27M 0.00
Other Non-Current Liabilities 39.00M 11.20M 11.08M 21.81M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 56.15M 19.26M 23.35M 21.81M
Total Liabilities 71.05M 37.98M 58.30M 56.19M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -23.98M 2.57M -9.69M 12.29M
Common Par 2.00K 2.00K 7.00K 6.00K
Additional Paid In Capital 350.25M 337.18M 296.94M 278.39M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -374.23M -334.61M -306.64M -266.10M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 1.00K 0.00 0.00 2.00K
Total Capitalization -23.98M 2.57M -9.69M 12.29M
Total Equity -23.98M 2.57M -9.69M 12.29M
Total Liabilities & Stock Equity 47.07M 40.55M 48.60M 68.48M
Total Common Shares Outstanding 17.28M 15.77M 7.21M 5.98M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 16.67M 12.47M 6.79M 5.54M
Diluted Weighted Shares Outstanding 16.67M 12.47M 6.79M 5.54M
Number of Employees 90 63 44 97
Number of Part-Time Employees 0 1 7 0
ALXA News

ALXA Alexza Pharmaceuticals Inc

Analysts Ratings for ALXA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ALXA ANALYST REPORT

Brokerage Partners

ALXA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs